R Marcolongo

5.2k total citations
154 papers, 2.9k citations indexed

About

R Marcolongo is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Epidemiology. According to data from OpenAlex, R Marcolongo has authored 154 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 40 papers in Rheumatology and 21 papers in Epidemiology. Recurrent topics in R Marcolongo's work include Viral Infections and Immunology Research (41 papers), Pericarditis and Cardiac Tamponade (13 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). R Marcolongo is often cited by papers focused on Viral Infections and Immunology Research (41 papers), Pericarditis and Cardiac Tamponade (13 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). R Marcolongo collaborates with scholars based in Italy, United States and Poland. R Marcolongo's co-authors include Alida L.P. Caforio, Sabino Iliceto, Isabelle Aujoulat, Alain Deccache, Francesco Laveder, Cristina Basso, Antonella Fioravanti, Giovanni Biasi, Anna Baritussio and Stefania Manganelli and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

R Marcolongo

139 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Marcolongo Italy 32 972 677 495 408 343 154 2.9k
A. Evans France 35 1.5k 1.6× 279 0.4× 970 2.0× 495 1.2× 332 1.0× 68 4.5k
Stacey S. Cofield United States 31 561 0.6× 714 1.1× 419 0.8× 193 0.5× 74 0.2× 81 3.2k
Olavi Ylikorkala Finland 44 614 0.6× 223 0.3× 373 0.8× 473 1.2× 440 1.3× 202 6.1k
Shaye Kivity Israel 32 421 0.4× 820 1.2× 381 0.8× 555 1.4× 107 0.3× 107 4.0k
H. A. Bird United Kingdom 33 233 0.2× 1.7k 2.6× 924 1.9× 307 0.8× 517 1.5× 133 4.5k
D. Wright United Kingdom 50 672 0.7× 114 0.2× 644 1.3× 627 1.5× 650 1.9× 140 10.1k
Jordi Casademont Spain 34 283 0.3× 431 0.6× 319 0.6× 633 1.6× 84 0.2× 141 3.7k
W.J. Sluiter Netherlands 27 431 0.4× 176 0.3× 685 1.4× 436 1.1× 85 0.2× 51 2.8k
Grzegorz Mazur Poland 33 654 0.7× 209 0.3× 206 0.4× 282 0.7× 78 0.2× 323 5.1k
Connie Chen United States 30 666 0.7× 371 0.5× 2.4k 4.8× 205 0.5× 496 1.4× 95 5.3k

Countries citing papers authored by R Marcolongo

Since Specialization
Citations

This map shows the geographic impact of R Marcolongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Marcolongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Marcolongo more than expected).

Fields of papers citing papers by R Marcolongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Marcolongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Marcolongo. The network helps show where R Marcolongo may publish in the future.

Co-authorship network of co-authors of R Marcolongo

This figure shows the co-authorship network connecting the top 25 collaborators of R Marcolongo. A scholar is included among the top collaborators of R Marcolongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Marcolongo. R Marcolongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baritussio, Anna, Cristina Vicenzetto, Luisa Cacciavillani, et al.. (2025). Hydrocarbon Exposure in Myocarditis: Rare Toxic Cause or Trigger? Insights from a Biopsy-Proven Fulminant Viral Case and a Systematic Literature Review. International Journal of Molecular Sciences. 26(9). 4006–4006.
2.
Caforio, Alida L.P., Anna Baritussio, Cristina Vicenzetto, et al.. (2024). Long-Term Efficacy and Safety of Tailored Immunosuppressive Therapy in Immune-Mediated Biopsy-Proven Myocarditis: A Propensity-Weighted Study. European Journal of Heart Failure. 26(5). 1175–1185. 13 indexed citations
3.
Vicenzetto, Cristina, Anna Baritussio, Elena Pontara, et al.. (2024). Cellular Immunology of Myocarditis: Lights and Shades—A Literature Review. Cells. 13(24). 2082–2082. 2 indexed citations
4.
Vicenzetto, Cristina, Anna Baritussio, Darío Gregori, et al.. (2024). Aetiology, Treatment and Outcomes of Pericarditis: Long-Term Data from a Longitudinal Retrospective Single-Centre Cohort. Journal of Clinical Medicine. 13(22). 6900–6900. 2 indexed citations
5.
Pontara, Elena, Cristina Vicenzetto, Anna Baritussio, et al.. (2024). Prevalence and Correlates of Anti-DSG2 Antibodies in Arrhythmogenic Right Ventricular Cardiomyopathy and Myocarditis: Immunological Insights from a Multicenter Study. Journal of Clinical Medicine. 13(22). 6736–6736. 1 indexed citations
6.
Vicenzetto, Cristina, Anna Baritussio, Elena Pontara, et al.. (2024). The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review. Biomedicines. 12(6). 1156–1156. 4 indexed citations
7.
8.
Baritussio, Anna, Cristina Basso, Cristina Vicenzetto, et al.. (2023). Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis. Vaccines. 11(12). 1742–1742. 1 indexed citations
9.
10.
Tymińska, Agata, Krzysztof Ozierański, Agnieszka Kapłon‐Cieślicka, et al.. (2022). Personalized Management of Myocarditis and Inflammatory Cardiomyopathy in Clinical Practice. Journal of Personalized Medicine. 12(2). 183–183. 15 indexed citations
11.
Lioncino, Michele, Emanuele Monda, Santo Dellegrottaglie, et al.. (2022). Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis. SHILAP Revista de lepidopterología. 12(2). 133–141. 1 indexed citations
12.
Ozierański, Krzysztof, Agata Tymińska, R Marcolongo, et al.. (2020). Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?. Journal of Cardiac Failure. 27(1). 92–96. 31 indexed citations
13.
Marcolongo, R, et al.. (2015). La biopsia endomiocardica nella miocardite acuta: per tutti i pazienti. Giornale italiano di cardiologia. 16(10). 533–8. 4 indexed citations
14.
Cacciatore, Giuseppe, et al.. (2014). Lo studio ICAP. Giornale italiano di cardiologia. 15(7). 393–6. 1 indexed citations
15.
Tanas, Rita, Nicola Corciulo, R Marcolongo, et al.. (2012). 63 – Therapeutic education as common tool in the prevention and early treatment of childhood obesity. Public Health Nutrition. 15(8A). 1582–1582. 1 indexed citations
16.
Briani, Chiara, Andrea Doria, R Marcolongo, et al.. (2007). Increased titres of IgM anti-heparan sulfate antibody in Behçet's disease.. PubMed. 24(5 Suppl 42). S104–7. 8 indexed citations
17.
Bellotto, Fabio, et al.. (1999). Respiratory symptoms and home environment in children. Thorax. 54(4). 376–376. 2 indexed citations
18.
Paroni, Rita, Antonella Fioravanti, L. Fattorini, et al.. (1991). Bioavailability of diclofenac sodium with vaginal administration in healthy women. Current Therapeutic Research. 50(2). 200–204. 4 indexed citations
19.
Giordano, N., et al.. (1984). Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine.. BMJ. 289(6450). 961–962. 23 indexed citations
20.
Camarri, E, R Marcolongo, & Francesco Fıcı. (1978). Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(11). 527–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Evans Breakdown of academic impact, for papers by Stacey S. Cofield Breakdown of academic impact, for papers by Olavi Ylikorkala Breakdown of academic impact, for papers by Shaye Kivity Breakdown of academic impact, for papers by H. A. Bird Breakdown of academic impact, for papers by D. Wright Breakdown of academic impact, for papers by Jordi Casademont Breakdown of academic impact, for papers by W.J. Sluiter Breakdown of academic impact, for papers by Grzegorz Mazur Breakdown of academic impact, for papers by Connie Chen
Rankless by CCL
2026